Ocugen, Inc. OCGN
0.74 USD -0.02 (-2.31%)
Regular-session close
0.78 +0.04 +5.44%
Pre-market · Nov 19, 4:00 AM ET
0.725 Day range 0.7961
0.691 52-week range 2.73
- YTD
- -45.24%
- 1 year
- -35.16%
News
marketbeat.com Ocugen Eyes 2027 Trial Results and FDA Filing for Lead Gene Therapy Ocugen NASDAQ: OCGN expects pivotal data for its lead experimental gene therapy for retinitis pigmentosa in the first quarter of 2027, a milestone that could set up a regulatory filing later that…benzinga.com UPDATE: Ocugen Q3 Adj. EPS $(0.06), Inline, Sales $1.951M Beat $1.098M Estimate Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 14.29 percent increase over losses of $(0.07) per share from the same period…
benzinga.com Ocugen Q3 2026 Earnings Call Transcript Ocugen (NASDAQ:OCGN) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide real-time…benzinga.com Ocugen Q3 EPS $(0.01) Beats $(0.06) Estimate, Sales $1.951M Beat $1.098M Estimate Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.06) by 83.33 percent. This is a 85.71 percent increase over losses of $(0.07) per…
